Inhibitory role of peroxisome proliferator-activated receptor gamma in hepatocarcinogenesis in mice and in vitro-Reference-Cited by-全球学者库

Inhibitory role of peroxisome proliferator-activated receptor gamma in hepatocarcinogenesis in mice and in vitro

Published:2010-01-28 Issue:6 Volume:51 Page:2008-2019
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Yu Jun,Shen Bo,Chu Eagle S. H.,Teoh Narci,Cheung Kin-Fai,Wu Chung-Wah,Wang Shiyan,Lam Cleo N. Y.,Feng Hai,Zhao Junhong,Cheng Alfred S. L.,To Ka-Fai,Chan Henry L. Y.,Sung Joseph J. Y.

Publisher

Wiley

Subject

Hepatology

Reference37 articles.

1. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005

2. Peroxisome proliferators-activated receptor gamma and carcinomas;Koeffer;Clin Cancer Res,2003

3. Present concepts and future outlook: function of peroxisome proliferator-activated receptors (PPARs) for pathogenesis, progression, and therapy of cancer;Sertznig;J Cell Physiol,2007

4. Peroxisome proliferator-activated receptor modulators as potential chemopreventive agents;Kopelovich;Mol Cancer Ther,2002

5. Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonists;Grommes;Lancet Oncol,2004

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Roles of peroxisome proliferator‐activated receptors in hepatocellular carcinoma;Journal of Cellular and Molecular Medicine;2023-11-20

2. An Overview of the Role of Peroxisome Proliferator-activated Receptors in Liver Diseases;Journal of Clinical and Translational Hepatology;2023-11-15

3. BEX1 supports the stemness of hepatoblastoma by facilitating Warburg effect in a PPARγ/PDK1 dependent manner;British Journal of Cancer;2023-09-15

4. Non-alcoholic fatty liver disease and diabetes mellitus as growing aetiologies of hepatocellular carcinoma;JHEP Reports;2023-09

5. The endocannabinoid system, a new gatekeeper in the pharmacology of human hepatocellular carcinoma;Environmental Research;2023-07